Chemoprevention of Prostate Cancer

Timothy C. Brand; Edith D. Canby-Hagino; A. Pratap Kumar; Rita Ghosh; Robin J. Leach; Ian M. Thompson

doi:10.1016/j.hoc.2006.03.012

Chemoprevention of Prostate Cancer

Timothy C. Brand, Edith D. Canby-Hagino, A. Pratap Kumar, Rita Ghosh, Robin J. Leach, Ian M. Thompson

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Prostate cancer is a common malignancy with multiple potential opportunities for cancer prevention. As the genetic basis of this malignancy is further understood, prevention strategies will be developed for individual patients based on specific risk factors and pathways of carcinogenesis. The PCPT has conclusively proven that prostate cancer prevention is possible. The results of the SELECT should be available within several years. An enormous challenge for the medical community will be the development of an efficient strategy to evaluate the substantial number of dietary, behavioral, and pharmacologic prevention opportunities. Ultimately, the goal of prostate cancer prevention is to (1) identify men who are destined to develop clinically significant prostate cancer, and (2) provide individualized agents to prevent disease development.

Original language	English (US)
Pages (from-to)	831-843
Number of pages	13
Journal	Hematology/Oncology Clinics of North America
Volume	20
Issue number	4
DOIs	https://doi.org/10.1016/j.hoc.2006.03.012
State	Published - Aug 2006

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.hoc.2006.03.012

Cite this

@article{51bd2e2f37f946619a553555812e42a1,

title = "Chemoprevention of Prostate Cancer",

abstract = "Prostate cancer is a common malignancy with multiple potential opportunities for cancer prevention. As the genetic basis of this malignancy is further understood, prevention strategies will be developed for individual patients based on specific risk factors and pathways of carcinogenesis. The PCPT has conclusively proven that prostate cancer prevention is possible. The results of the SELECT should be available within several years. An enormous challenge for the medical community will be the development of an efficient strategy to evaluate the substantial number of dietary, behavioral, and pharmacologic prevention opportunities. Ultimately, the goal of prostate cancer prevention is to (1) identify men who are destined to develop clinically significant prostate cancer, and (2) provide individualized agents to prevent disease development.",

author = "Brand, {Timothy C.} and Canby-Hagino, {Edith D.} and {Pratap Kumar}, A. and Rita Ghosh and Leach, {Robin J.} and Thompson, {Ian M.}",

year = "2006",

month = aug,

doi = "10.1016/j.hoc.2006.03.012",

language = "English (US)",

volume = "20",

pages = "831--843",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Chemoprevention of Prostate Cancer

AU - Brand, Timothy C.

AU - Canby-Hagino, Edith D.

AU - Pratap Kumar, A.

AU - Ghosh, Rita

AU - Leach, Robin J.

AU - Thompson, Ian M.

PY - 2006/8

Y1 - 2006/8

N2 - Prostate cancer is a common malignancy with multiple potential opportunities for cancer prevention. As the genetic basis of this malignancy is further understood, prevention strategies will be developed for individual patients based on specific risk factors and pathways of carcinogenesis. The PCPT has conclusively proven that prostate cancer prevention is possible. The results of the SELECT should be available within several years. An enormous challenge for the medical community will be the development of an efficient strategy to evaluate the substantial number of dietary, behavioral, and pharmacologic prevention opportunities. Ultimately, the goal of prostate cancer prevention is to (1) identify men who are destined to develop clinically significant prostate cancer, and (2) provide individualized agents to prevent disease development.

AB - Prostate cancer is a common malignancy with multiple potential opportunities for cancer prevention. As the genetic basis of this malignancy is further understood, prevention strategies will be developed for individual patients based on specific risk factors and pathways of carcinogenesis. The PCPT has conclusively proven that prostate cancer prevention is possible. The results of the SELECT should be available within several years. An enormous challenge for the medical community will be the development of an efficient strategy to evaluate the substantial number of dietary, behavioral, and pharmacologic prevention opportunities. Ultimately, the goal of prostate cancer prevention is to (1) identify men who are destined to develop clinically significant prostate cancer, and (2) provide individualized agents to prevent disease development.

UR - http://www.scopus.com/inward/record.url?scp=33746029437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746029437&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2006.03.012

DO - 10.1016/j.hoc.2006.03.012

M3 - Review article

C2 - 16861117

AN - SCOPUS:33746029437

SN - 0889-8588

VL - 20

SP - 831

EP - 843

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

IS - 4

ER -

Chemoprevention of Prostate Cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this